Global Gastroenterology Market Analysis By Product[Devices, Therapeutics(Biologics/ Biosimilars, Antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents, Other Drug Types)], By Distribution Channel(Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Application(Crohn's Disease, Ulcerative Colitis, GERD, IBS, Peptic Ulcer Disease, Colorectal Cancer, Gallbladder and Biliary Tract Disorders, Pancreatitis, Pancreatic Cancer, Others), By Route of Administration(Injectable, Oral, Others), By End Users(Hospitals, Clinics and Ambulatory Surgical Centers, Diagnostic Centers) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Oct 2024
- Report ID: 130394
- Number of Pages: 365
- Format:
-
keyboard_arrow_up
-
-
- Abbott Laboratories
- Johnson & Johnson
- AbbVie Inc. Company Profile
- Salix Pharmaceuticals
- GlaxoSmithKline Plc.
- ALLERGAN
- Takeda Pharmaceutical Company Limited
- AstraZeneca Plc Company Profile
- Astellas Pharma US Inc.
- Pfizer Inc Company Profile
- Other Key Players
- settingsSettings
Our Clients
- 130394
- Oct 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
